Cargando…
Normal and Functional TP53 in Genetically Stable Myxoid/Round Cell Liposarcoma
Myxoid/round-cell liposarcoma (MLS/RCLS) is characterized by either the fusion gene FUS-DDIT3 or the less commonly occurring EWSR1-DDIT3 and most cases carry few or no additional cytogenetic changes. There are conflicting reports concerning the status and role of TP53 in MLS/RCLS. Here we analysed f...
Autores principales: | Ståhlberg, Anders, Kåbjörn Gustafsson, Christina, Engtröm, Katarina, Thomsen, Christer, Dolatabadi, Soheila, Jonasson, Emma, Li, Chieh-Yuan, Ruff, David, Chen, Shiaw-Min, Åman, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231113/ https://www.ncbi.nlm.nih.gov/pubmed/25393000 http://dx.doi.org/10.1371/journal.pone.0113110 |
Ejemplares similares
-
Cell Senescence in Myxoid/Round Cell Liposarcoma
por: Kåbjörn Gustafsson, Christina, et al.
Publicado: (2014) -
Different HSP90 Inhibitors Exert Divergent Effect on Myxoid Liposarcoma In Vitro and In Vivo
por: Vannas, Christoffer, et al.
Publicado: (2022) -
FUS-DDIT3 Fusion Oncoprotein Expression Affects JAK-STAT Signaling in Myxoid Liposarcoma
por: Dolatabadi, Soheila, et al.
Publicado: (2022) -
Identification of inhibitors regulating cell proliferation and FUS-DDIT3 expression in myxoid liposarcoma using combined DNA, mRNA, and protein analyses
por: Svec, David, et al.
Publicado: (2018) -
JAK–STAT signalling controls cancer stem cell properties including chemotherapy resistance in myxoid liposarcoma
por: Dolatabadi, Soheila, et al.
Publicado: (2019)